referring to wncn
Survivors speak out about racial disparities in breast cancer
Survivors speak out about racial disparities in breast cancerHealth officials say white women are more likely to be diagnosed with breast cancer while non-white women, mainly black or Hispanic women, are more likely to die from it.(Source: WBTV)One in eight women are diagnosed with breast cancer, but new research shows the disparities in how different people are affected.Dr. Nadine Barrett from Duke University says she found white women are more likely to be diagnosed with breast cancer while non-white women — mainly black or Hispanic women — are more likely to die from it."It's disappointing," Dr. Barrett said.
not to mention niagara-gazette
GUEST VIEW: No more excuses, get your breast cancer screening
GUEST VIEW: No more excuses, get your breast cancer screeningWith your existing account from... {* loginWidget *}{* #socialRegistrationForm *} {* socialRegistration_firstName *} {* socialRegistration_lastName *} {* socialRegistration_emailAddress *} {* socialRegistration_displayName *} By clicking "Sign in", you confirm that you accept our terms of service and have read and understand privacy policy .{* /socialRegistrationForm *}We have sent a confirmation email to {* emailAddressData *}.Please check your email and click on the link to activate your account.Thank you for registering!
coupled with kpax
Kalispell rodeo clinic to raise breast cancer awareness - KPAX.com
Kalispell rodeo clinic to raise breast cancer awareness - KPAX.comIt's a sobering thought -- breast cancer is the most commonly diagnosed cancer among women and each year some 40,000 women will die from the disease.That's why local non-profit Chicks n Chaps is saddling up to raise awareness and money to fight breast cancer in the Kalispell community.The organization is hosting a Women's Rodeo Clinic at the Northwest Montana Fair & Rodeo Grounds.Event organizer Amy Tangedahl says the rodeo clinic gives women a "taste of the rodeo" by learning rodeo basics.
in like manner eurekalert
Sampling method used for new breast cancer tests may lead to underestimation of risk
Sampling method used for new breast cancer tests may lead to underestimation of riskPITTSBURGH, July 28, 2016 - Not only is breast cancer more than one disease, but a single breast cancer tumor can vary within itself, a finding that University of Pittsburgh Cancer Institute (UPCI) researchers discovered has the potential to lead to very different patient treatment plans depending on the tumor sample and diagnostic testing used.The results, reported online and scheduled for an upcoming issue of the journal Clinical Cancer Research, demonstrate that tumor sampling techniques used with newly developed "personalized medicine" gene expression profile tests may need to be refined to ensure that the most appropriate tumor sections are selected for testing."These tests are a good thing--they've done an incredible job identifying women with breast cancers that have a low risk of recurrence who don't need chemotherapy, saving them from the toxicity and discomfort of unnecessary treatment," said Adrian V. Lee, Ph.D., professor of pharmacology and chemical biology at UPCI, partner with UPMC CancerCenter."However, as with any new technology, we need to understand how these tests work, and we're finding that the sampling process, which involves liquefying tumors, loses information that could be important in determining the best treatment plan for patients with more aggressive tumors."
No comments:
Post a Comment